The US Food and Drug Administration granted approval for a drug combination in the treatment of renal cell carcinoma.


Intravesical installation with gemcitabine following transurethral resection of bladder tumor is associated with a reduced recurrence rate of non-muscle invasive bladder cancer in patients with low-grade disease.
In a recent study, researchers compared the effectiveness of chemotherapy plus radiotherapy vs chemotherapy alone in patients with locally advanced bladder cancer.

The National Comprehensive Cancer Network (NCCN) recently issued an updated version of their guidelines for varying histologies of kidney cancer.

Read More

Some health care services are rarely offered among older patients in the perioperative period for kidney cancer.

Read More

Research in Review

A look at 14 years of health care trends has revealed that the percentage of patients receiving treatment for metastatic renal cell carcinoma (mRCC) is growing as providers shift toward targeted therapeutic approaches. 

Read More

Subscribe to Kidney Cancer